This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Natera, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hossein Tabriziani and Transplant Rejection Detection.
Introduction
Hossein Tabriziani is an inventor based in San Diego, California, and is associated with Natera, Inc. His patent work addresses methods for assessing transplant rejection through analysis of biological samples.
Latest Patents
Tabriziani is named on 1 patent, titled “Methods for Determination of Transplant Rejection.” The disclosed methods measure the amount of torque teno virus (TTV) and donor-derived cell-free DNA in a transplant recipient’s blood, plasma, serum, or urine. The results are used to assess whether donor-derived cell-free DNA exceeds a threshold associated with rejection and whether the TTV level indicates a change in immune response.
Career Highlights
His listed invention focuses on combining measurements of donor-derived cell-free DNA and TTV to support the determination of transplant rejection and immune response.
Collaborations
The provided information lists Paul Van Hummelen and Jessica Tang as Tabriziani’s coworkers.
Conclusion
Hossein Tabriziani’s patent describes a sample-analysis approach that combines donor-derived cell-free DNA and TTV measurements to help assess transplant rejection and immune response.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile